Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

EL

What Is the Outlook for Estee Lauder Shares?

Shares of Estee Lauder rose to $91.51 during today's morning trading session. Despite the 2.7% change, the Large-Cap Household & Personal Products company still trades 10.88% above its average analyst target price of $82.53. So there may be further downside for the Household & Personal Products stock. Estee Lauder has target prices ranging from $56.2 to $120.0 per share, and its average rating is hold.

The stock has an average amount of shares sold short at 5.6%, and a short ratio of 3.24. The company's insiders own 0.43% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 94.0% of Estee Lauder's shares being owned by this investor type.

Institutions Invested in Estee Lauder

Date Reported Holder Percentage Shares Value
2025-06-30 Vanguard Group Inc 11% 26,904,441 $2,462,025,453
2025-03-31 Blackrock Inc. 7% 15,624,868 $1,429,831,704
2025-03-31 FMR, LLC 6% 14,607,259 $1,336,710,302
2025-03-31 State Street Corporation 5% 10,789,580 $987,354,488
2025-03-31 Eagle Capital Management LLC 4% 9,678,460 $885,675,895
2025-03-31 JPMORGAN CHASE & CO 4% 8,336,641 $762,886,035
2025-03-31 Independent Franchise Partners, LLP 3% 7,976,434 $729,923,492
2025-03-31 Invesco Ltd. 3% 6,681,785 $611,450,159
2025-06-30 Geode Capital Management, LLC 3% 5,912,792 $541,079,608
2025-03-31 Capital World Investors 2% 5,711,602 $522,668,711

Besides an analyst belief that shares are overpriced, other market factors point to there being negative market sentiment on Estee Lauder.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS